Arthritis News - 2004

December

• Pfizer Releases Statement on Cardiovascular Safety of Celecoxib (Celebrex) 12-23-04
• Pregnancy Outcomes in Infliximab Exposed Women 12-21-04
• Impact of Shared Epitope Genes and Smoking on Risk of Seropositive RA Development 12-10-04

November

• American College of Rheumatology Annual Meeting Highlights 11-20-04

October

• Remicade Label Changed to Include Risk of Lymphoma Similar to Other TNF Inhibitors 10-13-04
• Etanercept (Enbrel) 50 mg Once-Weekly Dosing Now Available
  10-4-04
• Infliximab (Remicade) Now Approved as First-Line Treatment for Rheumatoid Arthritis
  10-4-04

September

• Merck Announces Worldwide Voluntary Withdrawal of Vioxx
  9-30-04
• What is the Relationship of RA Disease Activity to Radiographic Progression of Joint Damage?
  9-20-04
• What is the Relationship of RA Disease Activity to Radiographic Progression of Joint Damage?
  9-20-04
• Rofecoxib (Vioxx^®) Receives FDA Approval for the Treatment of JRA
  9-17-04

August

• GI and Cardiovascular Events with Lumiracoxib - Results from the TARGET Trial
  8-25-04
• Anti-IL-6 Monoclonal Antibody (MRA) Proves Efficacious for the Treatment of RA
  8-13-04
• Mobic® Receives FDA Approval for Treatment in RA
  8-12-04

July

• Combination Therapy with Etanercept and Anakinra for Rheumatoid Arthritis
  7-26-04
• Atorvastatin for the Treatment of Rheumatoid Arthritis
  7-12-04
• Medicare Demonstration Project Runs July 6-September 30, 2004
  7-2-04

June

• Depletion of B cells by rituximab (Rituxan®) shows efficacy for the treatment of rheumatoid arthritis (RA)
  6-23-04

May

• Adalimumab is Safe and Efficacious as Monotherapy in Patients with Rheumatoid Arthritis
  5-19-04
• Adalimumab Inhibits the Progression of Structural Joint Damage
  5-13-04
• Is Citrullinated Vimentin a Potential Antigenic Target for RA Specific Antibodies?
  5-11-04
• Role of Diet in the Incidence of Gout
  5-3-04
  

April

• Do GPI Antibodies Serve as Biomarkers for Extraarticular Complications of RA?
  4-19-04
• Efficacy of Intramuscular (IM) Methotrexate in the Treatment of RA
  4-12-04

March

• Incidence of TB in Patients with RA Treated and Untreated with Anti-TNF Therapy
  3-31-04
• Results of TEMPO Trial Now Published
  3-15-04
• Does Reinstituting Anti-TNF Therapy Following Relapse in Remission in RA Have Similar Efficacy?
  3-4-04

February

• Clinical Trials of Hyaluronic Acid Reflect Significant Publication Bias
  2-17-04
• In Vivo Inhibition of NF-kB is Effective in Mouse Model of Inflammatory Arthritis 2-6-04

January

• Vitamin D Intake Is Inversely Associated With Rheumatoid Arthritis 1-27-04
• Largest Ever Study of Osteoarthritis of the Knee is Seeking Volunteersa1-9-04
• Relationship Between Body Weight Gain and Significant Knee, Hip, and Back Pain in Among Older Americansa1-7-04

*Arthritis news summaries and editorials are written by Jon Giles, M.D., Joan Bathon, M.D., and Clifton O. Bingham, M.D. unless otherwise noted.

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.